Lifecore Biomedical Inc (LFCR) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Nov 24 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lifecore Biomedical Inc   (NASDAQ: LFCR)


Lifecore Biomedical Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lifecore Biomedical Inc's ROI in the first quarter of 2026?
Lifecore Biomedical Inc recorded a cumulative net loss of $-46 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -22.27%.

Within the Healthcare sector 345 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3078 to 3295.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Sep 30 2025)
I. Quarter		 (May 25 2025)
IV. Quarter		 (Feb 23 2025)
III. Quarter		 (Nov 24 2024)
II. Quarter
Y / Y Investment Change TTM -7.29 % -6.07 % -6.36 % 10.94 % 12.65 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 205 205 209 207 215
Return On Investment (TTM) -22.27 % -18.56 % -21.1 % -22.18 % -7.36 %
LFCR's Overall Ranking # 3295 # 3078 # 2687 # 46 #
Seq. Investment Change TTM -1.21 % -0.13 % -5.74 % -0.32 % 0.09 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -46 -39 -44 -49 -16

LFCR Company Profile >> Back to LFCR Roi Comparisons >> See Annual LFCR Return On Investment



Return On Investment LFCR's Ranking
Within: No.
Industry # 120
Sector # 346
Overall # 3295

Return On Investment Statistics
High Average Low
5.47 %
-31.51 %
-89.27 %
(May 26 2024)   (May 28 2023)







Financial Statements
Lifecore Biomedical Inc's I. Quarter Investments $ 205 Millions LFCR's Balance sheet
Lifecore Biomedical Inc's I. Quarter Income $ -16 Millions Quarterly LFCR's Income Statement
LFCR's Income by Division See LFCR's Income by Division


LFCR Annual Return On Investment (May 25 2025)
2025		 (May 26 2024)
2024		 (May 28 2023)
2023		 (May 29 2022)
2022
Total Investments in Millions 209 215 214 91 371
Y / Y Investment Growth -2.75 % 0.39 % 135.74 % -75.52 % 10.19 %
Net Income in Millions -44 12 -100 -115 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -21.12 % 5.59 % -46.47 % -126.18 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LFCR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LFCR's Competitors
Subscribers only: Roi for Lifecore Biomedical Inc's Suppliers
Subscribers only: Return On Investment for LFCR's Customers

Other Ratios
LFCR's Roa LFCR's Inventory Turnover Ratio LFCR's Growth Rates LFCR's Dividend Statistics
LFCR's Profitability Ratios LFCR's Asset Turnover Ratio LFCR's Dividend Growth
LFCR's Roe LFCR's Valuation Ratios LFCR's Financial Strength Ratios LFCR's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T06:10:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.